tranexamic acid has been researched along with Connective Tissue Diseases in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Connective Tissue Diseases: A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rampotas, A | 1 |
| Watson, E | 1 |
| Burton, K | 1 |
| Hill, QA | 1 |
| Pavord, S | 1 |
1 other study available for tranexamic acid and Connective Tissue Diseases
| Article | Year |
|---|---|
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Combined M | 2022 |